Screening for anal cancer in women

Anna Barbara Moscicki, Teresa M. Darragh, J. Michael Berry-Lawhorn, Jennifer M. Roberts, Michelle J. Khan, Lori A. Boardman, Elizabeth Chiao, Mark H. Einstein, Stephen E. Goldstone, Naomi Jay, Wendy M. Likes, Elizabeth A. Stier, Mark L. Welton, Dorothy J. Wiley, Joel M. Palefsky

Research output: Contribution to journalArticlepeer-review

113 Scopus citations


Objective: The incidence of anal cancer is higher in women than men in the general population and has been increasing for several decades. Similar to cervical cancer, most anal cancers are associated with human papillomavirus (HPV), and it is believed that anal cancers are preceded by anal high-grade squamous intraepithelial lesions (HSIL). Our goals were to summarize the literature on anal cancer, HSIL, and HPV infection in women and to provide screening recommendations in women. Methods: A group of experts convened by the American Society for Colposcopy and Cervical Pathology and the International Anal Neoplasia Society reviewed the literature on anal HPV infection, anal SIL, and anal cancer in women. Results: Anal HPV infection is common in women but is relatively transient in most. The risk of anal HSIL and cancer varies considerably by risk group, with human immunodeficiency virus-infected women and those with a history of lower genital tract neoplasia at highest risk compared with the general population.

Original languageEnglish
Pages (from-to)S27-S42
JournalJournal of Lower Genital Tract Disease
Issue number3
StatePublished - 2015


Dive into the research topics of 'Screening for anal cancer in women'. Together they form a unique fingerprint.

Cite this